Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to _________________ Commission File Number: 001-38386 CARDLYTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware ...

| --- | --- | |-----------------------------------|-------| | | | | | | | | | | | | | | | | CARDLYTICS Q1 2022 | | | Earnings Presentation May 2, 2022 | | | | | Disclaimer This presentation includes forward-looking statements. All statements contained in this presentation other than statements of historical facts, including statements regarding expectations about future financial performance or results of Cardlytics, Inc. ("Cardlytics," "we," "us," or "our) including the potential benefits of our acquisitio ...

Cardlytics, Inc. (NASDAQ:CDLX) Q4 2021 Earnings Conference Call March 1, 2022 5:00 PM ET Company Participants Kirk Somers - Chief Legal & Privacy Officer Lynne Laube - Chief Executive Officer, Co-Founder, & Director Andy Christiansen - Chief Financial Officer Conference Call Participants Douglas Anmuth - JPMorgan. Jason Kreyer - Craig-Hallumjk Kyle Peterson - Needham Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcr ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to _________________ Commission File Number: 001-38386 CARDLYTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 26-3 ...

| --- | --- | |-------------------------------------------|-------| | | | | | | | | | | | | | CARDLYTICS Q4 2021 Earnings Presentation | | | March 1, 2022 | | Disclaimer This presentation includes forward-looking statements. All statements contained in this presentation other than statements of historical facts, including statements regarding expectations about future financial performance or results of Cardlytics, Inc. ("Cardlytics," "we," "us," or "our) including the potential benefits of our acquisitions ...

Cardlytics, Inc. (NASDAQ:CDLX) Q3 2021 Earnings Conference Call November 2, 2021 5:00 PM ET Company Participants Kirk Somers - Chief Legal & Privacy Officer Lynne Laube - Chief Executive Officer & Co-Founder Andy Christiansen - Chief Financial Officer Conference Call Participants Kyle Peterson - Needham Aaron Kessler - Raymond James Operator Thank you for standing by, and welcome to the Cardlytics Q3 2021 Financial Results Conference Call. At this time, all participants are in listen-only mode. After the sp ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to _________________ Commission File Number: 001-38386 CARDLYTICS, INC. (Exact Name of Registrant as Specified in its Charter) Dela ...

| --- | --- | --- | |-----------------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | August 3, 2021 Earnings Presentation Q2 2021 | | | | | | | | | | | | | | | cardlytics Disclaimer This presentation includes forward-looking statements. All statements contained in this presentation other than statements of historical facts, including statements regard financial performance or results of Cardlytics, Inc. ("Cardlytics, " "we," our) including our financial guidance for the th ...

Cardlytics, Inc. (NASDAQ:CDLX) Q2 2021 Earnings Conference Call August 3, 2021 5:00 PM ET Company Participants Lynne Laube - CEO and Co-Founder Andy Christiansen - CFO Conference Call Participants Jason Kreyer - Craig-Hallum Aaron Kessler - Raymond James Karl Peters - Needham Charles Norman - Wells Fargo Operator Unidentified Company Representative Good evening, and welcome to the Cardlytics Second Quarter 2021 Financial Results Call. Before we begin, let me remind everyone that today's discussion will cont ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to _________________ Commission File Number: 001-38386 CARDLYTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware ...